Lightness and Dark in the Ibogaine Scene

Jun 21, 2018

Speakers

About

Research for a film on ibogaine has taken me to the UK, Spain, Portugal, Greece, South Africa, the US, Canada, Mexico and Brazil. I have seen light and shadows along the way. Ibogaine was studied through the MKUltra programme by Harris Isbell. In 1955, Isbell studied the effects of ibogaine in 8 detoxified subjects. I’ll explore ibogaine failing to medicalise in the 1990s examining what happened at the NIDA meetings. Was funding for ibogaine stopped for scientific reasons, a lack of commercial incentives, or more shadowy “political” reasons: Big Pharma investing in opioid-based drugs? Ibogaine went underground. A network of over 90 clinics around the globe are treating thousands of people with a specific condition, with the number of clinics growing rapidly. Safety from clinic to clinic lies along a spectrum: many 1000s of clients have had their addiction interrupted (at least temporarily), while 10s of people have died during (or immediately after) treatment. I will end with a discussion of the supply chain, with large quantities of iboga root bark smuggled out of Gabon: the plant is now threatened. I shall ask what it will take to raise more awareness of ethically and sustainably sourced ibogaine and closer relations to forest communities in Gabon.

Organizer

Categories

Like the format? Trust SlidesLive to capture your next event!

Professional recording and live streaming, delivered globally.

Sharing

Recommended Videos

Presentations on similar topic, category or speaker

Interested in talks like this? Follow Beyond Psychedelics